Respiratory Infection

Respiratory
1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Biotest Pharmaceuticals
Biotest PharmaceuticalsGermany - Dreieich
1 program
1
TrimodulinPhase 31 trial
Active Trials
NCT05531149TerminatedEst. May 2025

Trial Timeline

Clinical trial activity over time

2022
2023
2024
2025
2026
Biotest PharmaceuticalsTrimodulin

Clinical Trials (1)

Efficacy and Safety of Trimodulin (BT588) in Subjects With CAP Including COVID-19 Pneumonia

Start: Dec 2022Est. completion: May 2025
Phase 3Terminated

Related Jobs in Respiratory

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 late-stage (Phase 3) programs — potential near-term approvals
1 companies competing in this space